tumor endothelial marker antibodies (Genzyme/John Hopkins)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nametumor endothelial marker antibodies (Genzyme/John Hopkins)
Drug Alias NameTEMS (GMO/Johns Hopkins)antiangiogenesis gene therapy (Genzyme Molecular/Johns Hopkins)TEMS antibodies (GMO/Johns Hopkins)TEMS (Genzyme Molecular/Johns Hopkins)antiangiogenesis gene therapy (GMO/Johns Hopkins) +[10] 
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyDiagnostic agent (In vivo)
Mechanisms of ActionEndosialin modulators
TargetsEndosialin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenzyme Molecular OncologyJohns Hopkins University School Of Medicine
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A